Association between cytokine polymorphisms and recurrent pregnancy loss: A review of current evidence.
cytokine polymorphisms
growth factors
interferons
interleukins
recurrent pregnancy loss
tumor necrosis factors
Journal
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174
Informations de publication
Date de publication:
06 May 2024
06 May 2024
Historique:
revised:
09
04
2024
received:
16
12
2023
accepted:
20
04
2024
medline:
6
5
2024
pubmed:
6
5
2024
entrez:
6
5
2024
Statut:
aheadofprint
Résumé
Cytokines are a type of protein that play an important role in the immune response and can also affect many physiological processes in the body. Cytokine polymorphisms refer to genetic variations or mutations that occur within the genes that code for cytokines, which may affect the level of cytokine production and function. Some cytokine polymorphisms have been associated with an increased risk of developing certain diseases, while others may be protective or have no significant effect on health. In recent years, the role of cytokine polymorphisms in the development of recurrent pregnancy loss (RPL) has been studied. RPL or miscarriage is defined as the occurrence of two or more consecutive pregnancy losses before the 20th week of gestation. There are diverse causes leading to RPL, including genetic, anatomical, hormonal, and immunological factors. With regard to cytokine polymorphisms, a few of them have been found to be associated with an increased risk of RPL, for instance, variations in the genes that code for interleukin-6, tumor necrosis factor-alpha, and interleukin-10. The exact mechanisms by which cytokine polymorphisms affect the risk of recurrent miscarriage are still being studied, and further research is essential to fully understand this complex condition. This brief review aims to summarize the recent literature on the association between cytokine polymorphisms and RPL.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.
Références
Holtmann H, Resch K. Cytokines. Naturwissenschaften. 1995;82(4):178‐187.
Liu C, Chu D, Kalantar‐Zadeh K, George J, Young HA, Liu G. Cytokines: from clinical significance to quantification. Adv Sci (Weinh). 2021;8(15):e2004433.
Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14(5):329‐342.
Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol. 2009;78(6):539‐552.
Stanley AC, Lacy P. Pathways for cytokine secretion. Physiology (Bethesda). 2010;25(4):218‐229.
Stow JL, Low PC, Offenhauser C, Sangermani D. Cytokine secretion in macrophages and other cells: pathways and mediators. Immunobiology. 2009;214(7):601‐612.
Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45(2):27‐37.
Dinarello CA. Historical insights into cytokines. Eur J Immunol. 2007;37(Suppl 1):S34‐S45.
Trenova AG, Slavov GS, Manova MG, Miteva LD, Stanilova SA. A role of cytokine gene polymorphisms in cognitive functioning. Folia Med (Plovdiv). 2018;60(2):191‐199.
Walter NA, McWeeney SK, Peters ST, Belknap JK, Hitzemann R, Buck KJ. Single‐nucleotide polymorphism masking. Alcohol Res Health. 2008;31(3):270‐271.
Komar AA. Silent SNPs: impact on gene function and phenotype. Pharmacogenomics. 2007;8(8):1075‐1080.
Hong Li Y, Marren A. Recurrent pregnancy loss: a summary of international evidence‐based guidelines and practice. Aust J Gen Pract. 2018;47(7):432‐436.
Tetruashvili N, Domar A, Bashiri A. Prevention of pregnancy loss: combining progestogen treatment and psychological support. J Clin Med. 2023;12(5):1827.
Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98.
Tise CG, Byers HM. Genetics of recurrent pregnancy loss: a review. Curr Opin Obstet Gynecol. 2021;33(2):106‐111.
Lash GE, Ernerudh J. Decidual cytokines and pregnancy complications: focus on spontaneous miscarriage. J Reprod Immunol. 2015;108:83‐89.
Yockey LJ, Iwasaki A. Interferons and proinflammatory cytokines in pregnancy and fetal development. Immunity. 2018;49(3):397‐412.
Wheeler VS. Interleukins: the search for an anticancer therapy. Semin Oncol Nurs. 1996;12(2):106‐114.
Mizel SB. The interleukins. FASEB J. 1989;3(12):2379‐2388.
Vilotic A, Nacka‐Aleksic M, Pirkovic A, Bojic‐Trbojevic Z, Dekanski D, Jovanovic KM. IL‐6 and IL‐8: an overview of their roles in healthy and pathological pregnancies. Int J Mol Sci. 2022;23(23):14574.
Yazdi AS, Ghoreschi K. The interleukin‐1 family. Adv Exp Med Biol. 2016;941:21‐29.
Equils O, Kellogg C, McGregor J, Gravett M, Neal‐Perry G, Gabay C. The role of the IL‐1 system in pregnancy and the use of IL‐1 system markers to identify women at risk for pregnancy complications. Biol Reprod. 2020;103(4):684‐694.
Miyakawa AA, Borin TF, Campos LCG, et al. Activation of interleukin‐1 beta in arterialized vein grafts and the influence of the ‐511C/T IL‐1beta gene polymorphism. J Cardiovasc Dev Dis. 2019;6(2):20.
Kim JO, Lee WS, Lee BE, et al. Interleukin‐1beta −511T>C genetic variant contributes to recurrent pregnancy loss risk and peripheral natural killer cell proportion. Fertil Steril. 2014;102(1):206‐212.e5.
Ma J, Zhang X, He G, Yang C. Association between TNF, IL1B, IL6, IL10 and IFNG polymorphisms and recurrent miscarriage: a case control study. Reprod Biol Endocrinol. 2017;15(1):83.
Wang T, Lu N, Cui Y, Tian L. Polymorphisms in interleukin genes and their association with the risk of recurrent pregnancy loss. Genes Genet Syst. 2019;94(3):109‐116.
Wang ZC, Yunis EJ, De los Santos MJ, Xiao L, Anderson DJ, Hill JA. T helper 1‐type immunity to trophoblast antigens in women with a history of recurrent pregnancy loss is associated with polymorphism of the IL1B promoter region. Genes Immun. 2002;3(1):38‐42.
Agrawal S, Parveen F, Faridi RM, Prakash S. Interleukin‐1 gene cluster variants and recurrent pregnancy loss among north Indian women: retrospective study and meta‐analysis. Reprod Biomed Online. 2012;24(3):342‐351.
Ali Rahmani S, Paknejad Z, Mohammadkhanlou M, Daneshparvar M. Association of of IL‐1 receptor antagonist (IL‐1RN) and interleukin‐1beta genes (IL‐1beta) polymorphisms with recurrent pregnancy loss in Iranian Azeri women. Horm Mol Biol Clin Invest. 2017;33(3):44.
Hefler LA, Tempfer CB, Unfried G, et al. A polymorphism of the interleukin‐1beta gene and idiopathic recurrent miscarriage. Fertil Steril. 2001;76(2):377‐379.
Linjawi S, Li TC, Laird S, Blakemore A. Interleukin‐1 receptor antagonist and interleukin‐1 beta polymorphisms in women with recurrent miscarriage. Fertil Steril. 2005;83(5):1549‐1552.
Nair RR, Khanna A, Singh K. Association of interleukin 1 receptor antagonist (IL1RN) gene polymorphism with recurrent pregnancy loss risk in the north Indian population and a meta‐analysis. Mol Biol Rep. 2014;41(9):5719‐5727.
Prins JR, Gomez‐Lopez N, Robertson SA. Interleukin‐6 in pregnancy and gestational disorders. J Reprod Immunol. 2012;95(1–2):1‐14.
Lee YH, Choi SJ, Ji JD. Association between IL‐6 −174 G/C, IL‐6 −634 G/C, and IFN‐gamma +874 A/T polymorphisms and susceptibility to recurrent pregnancy loss: a meta‐analysis. J Assist Reprod Genet. 2015;32(9):1421‐1427.
Nasiri M, Rasti Z. CTLA‐4 and IL‐6 gene polymorphisms: risk factors for recurrent pregnancy loss. Hum Immunol. 2016;77(12):1271‐1274.
Rasti Z, Nasiri M, Kohan L. The IL‐6 ‐634C/G polymorphism: a candidate genetic marker for the prediction of idiopathic recurrent pregnancy loss. Int J Reprod Biomed. 2016;14(2):103‐108.
Liu Q, Li Y, Li J, Wang Y, Mao B. Association of the IL‐6 gene rs1800796 polymorphism with recurrent pregnancy loss in a population of women from northwestern China: a case‐control study. J Obstet Gynaecol. 2022;42(7):2787‐2792.
El‐Hamid SA, El‐Khayat W. Relationship of the protein Z intron F G79A and IL6 C634G gene polymorphisms with the risk of recurrent pregnancy loss in Egyptian women. J Investig Med. 2011;59(4):655‐660.
Alkhuriji AF, Alhimaidi AR, Babay ZA, Wary AS. The relationship between cytokine gene polymorphism and unexplained recurrent spontaneous abortion in Saudi females. Saudi Med J. 2013;34(5):484‐489.
Bohiltea L, Radoi V. Interleukin‐6 and interleukin‐10 gene polymorphisms and recurrent pregnancy loss in Romanian population. Iran J Reprod Med. 2014;12(9):617‐622.
Daher S, Shulzhenko N, Morgun A, et al. Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol. 2003;58(1):69‐77.
Parveen F, Shukla A, Agarwal S. Cytokine gene polymorphisms in northern Indian women with recurrent miscarriages. Fertil Steril. 2013;99(2):433‐440.
Demirturk F, Ates O, Gunal O, Bozkurt N, Aysal T, Nacar MC. IL‐6 gene promoter polymorphisms: genetic susceptibility to recurrent pregnancy loss. Bratisl Lek Listy. 2014;115(8):479‐482.
Saraiva M, O'Garra A. The regulation of IL‐10 production by immune cells. Nat Rev Immunol. 2010;10(3):170‐181.
Gu C, Gong H, Zhang Z, Yang Z, Ma Y. Association of interleukin‐10 gene promoter polymorphisms with recurrent pregnancy loss: a meta‐analysis. J Assist Reprod Genet. 2016;33(7):907‐917.
Vigano P, Somigliana E, Mangioni S, Vignali M, Vignali M, Di Blasio AM. Expression of interleukin‐10 and its receptor is up‐regulated in early pregnant versus cycling human endometrium. J Clin Endocrinol Metab. 2002;87(12):5730‐5736.
Babbage SJ, Arkwright PD, Vince GS, et al. Cytokine promoter gene polymorphisms and idiopathic recurrent pregnancy loss. J Reprod Immunol. 2001;51(1):21‐27.
Bahadori M, Zarei S, Zarnani AH, et al. IL‐6, IL‐10 and IL‐17 gene polymorphisms in Iranian women with recurrent miscarriage. Iran J Immunol. 2014;11(2):97‐104.
Karhukorpi J, Laitinen T, Karttunen R, Tiilikainen AS. The functionally important IL‐10 promoter polymorphism (−1082G→A) is not a major genetic regulator in recurrent spontaneous abortions. Mol Hum Reprod. 2001;7(2):201‐203.
Kamali‐Sarvestani E, Zolghadri J, Gharesi‐Fard B, Sarvari J. Cytokine gene polymorphisms and susceptibility to recurrent pregnancy loss in Iranian women. J Reprod Immunol. 2005;65(2):171‐178.
Qaddourah RH, Magdoud K, Saldanha FL, et al. IL‐10 gene promoter and intron polymorphisms and changes in IL‐10 secretion in women with idiopathic recurrent miscarriage. Hum Reprod. 2014;29(5):1025‐1034.
Soheilyfar S, Nikyar T, Fathi Maroufi N, et al. Association of IL‐10, IL‐18, and IL‐33 genetic polymorphisms with recurrent pregnancy loss risk in Iranian women. Gynecol Endocrinol. 2019;35(4):342‐345.
Turienzo A, Lledo B, Ortiz JA, et al. Prevalence of candidate single nucleotide polymorphisms on p53, IL‐11, IL‐10, VEGF and APOE in patients with repeated implantation failure (RIF) and pregnancy loss (RPL). Hum Fertil (Camb). 2020;23(2):117‐122.
Cochery‐Nouvellon E, Nguyen P, Attaoua R, et al. Interleukin 10 gene promoter polymorphisms in women with pregnancy loss: preferential association with embryonic wastage. Biol Reprod. 2009;80(6):1115‐1120.
Mashkina EV, Kovalenko KA, Fomina NV, Shkurat TP. Cytokine gene polymorphisms and early pregnancy loss. Russ J Genet Appl Res. 2015;5:500‐506.
Sudhir N, Kaur M, Singh S, Beri A, Kaur T, Kaur A. Impact of Interleukin‐10 promoter region polymorphisms on recurrent miscarriage: a case‐control approach. J Hum Reprod Sci. 2023;16(2):156‐165.
Kaplanski G. Interleukin‐18: biological properties and role in disease pathogenesis. Immunol Rev. 2018;281(1):138‐153.
Laskarin G, Strbo N, Crncic TB, et al. Physiological role of IL‐15 and IL‐18 at the maternal‐fetal interface. Chem Immunol Allergy. 2005;89:10‐25.
Chen H, Yang X, Du J, Lu M. Interleukin‐18 gene polymorphisms and risk of recurrent pregnancy loss: a systematic review and meta‐analysis. J Obstet Gynaecol Res. 2015;41(10):1506‐1513.
Al‐Khateeb GM, Sater MS, Finan RR, et al. Analysis of interleukin‐18 promoter polymorphisms and changes in interleukin‐18 serum levels underscores the involvement of interleukin‐18 in recurrent spontaneous miscarriage. Fertil Steril. 2011;96(4):921‐926.
Messaoudi S, Dandana M, Magdoud K, et al. Interleukin‐18 promoter polymorphisms and risk of idiopathic recurrent pregnancy loss in a Tunisian population. J Reprod Immunol. 2012;93(2):109‐113.
Zidan HE, Abdul‐Maksoud RS, Mowafy HE, Elsayed WSH. The association of IL‐33 and Foxp3 gene polymorphisms with recurrent pregnancy loss in Egyptian women. Cytokine. 2018;108:115‐119.
Kamrani A, Rahmani SA, Mosapour P, Chavoshi R. Association of IL‐33 gene rs16924159 polymorphism and recurrent pregnancy loss in Iranian Azeri women. Horm Mol Biol Clin Invest. 2020;41(4):10.
Yue J, Tong Y, Xie L, Ma T, Yang J. Genetic variant in IL‐33 is associated with idiopathic recurrent miscarriage in Chinese Han population. Sci Rep. 2016;6:23806.
Zidan HE, Rezk NA, Alnemr AA, Moniem MI. Interleukin‐17 and leptin genes polymorphisms and their levels in relation to recurrent pregnancy loss in Egyptian females. Immunogenetics. 2015;67(11–12):665‐673.
Messaoudi S, Al‐Khateeb GM, Dendana M, et al. Genetic variations in the interleukin‐21 gene and the risk of recurrent idiopathic spontaneous miscarriage. Eur Cytokine Netw. 2011;22(2):123‐126.
Saijo Y, Sata F, Yamada H, Kondo T, Kato EH, Kishi R. Single nucleotide polymorphisms in the promoter region of the interleukin‐6 gene and the risk of recurrent pregnancy loss in Japanese women. Fertil Steril. 2004;81(2):374‐378.
Tavasolian F, Abdollahi E, Samadi M. Association of the IL4R single‐nucleotide polymorphism I50V with recurrent spontaneous abortion (RSA). J Assist Reprod Genet. 2014;31(7):851‐856.
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669‐676.
Mitchell AC, Briquez PS, Hubbell JA, Cochran JR. Engineering growth factors for regenerative medicine applications. Acta Biomater. 2016;30:1‐12.
Knofler M. Critical growth factors and signalling pathways controlling human trophoblast invasion. Int J Dev Biol. 2010;54(2–3):269‐280.
Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 2013;153(1):13‐19.
Fisher SJ. Why is placentation abnormal in preeclampsia? Am J Obstet Gynecol. 2015;213(4 Suppl):S115‐S122.
Vagnini LD, Nascimento AM, Canas Mdo C, et al. The relationship between vascular endothelial growth factor 1154G/a polymorphism and recurrent implantation failure. Med Princ Pract. 2015;24(6):533‐537.
Papazoglou D, Galazios G, Papatheodorou K, et al. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. Fertil Steril. 2005;83(4):959‐963.
Su MT, Lin SH, Chen YC. Genetic association studies of angiogenesis‐ and vasoconstriction‐related genes in women with recurrent pregnancy loss: a systematic review and meta‐analysis. Hum Reprod Update. 2011;17(6):803‐812.
Samli H, Demir BC, Ozgoz A, Atalay MA, Uncu G. Vascular endothelial growth factor gene 1154G/A, 2578C/A, 460C/T, 936C/T polymorphisms and association with recurrent pregnancy losses. Genet Mol Res. 2012;11(4):4739‐4745.
Aggarwal S, Parveen F, Faridi RM, Phadke S, Borkar M, Agrawal S. Vascular endothelial growth factor gene polymorphisms in north Indian patients with recurrent miscarriages. Reprod Biomed Online. 2011;22(1):59‐64.
Lee HH, Hong SH, Shin SJ, Ko JJ, Oh D, Kim NK. Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion. Fertil Steril. 2010;93(4):1244‐1247.
Saboori S, Noormohammadi Z, Zare‐Karizi S. Genetic variation in vascular endothelial growth factor gene and its association with recurrent spontaneous abortion. Bratisl Lek Listy. 2016;117(2):80‐86.
Amin I, Pandith AA, Manzoor U, et al. Implications of VEGF gene sequence variations and its expression in recurrent pregnancy loss. Reprod Biomed Online. 2021;43(6):1035‐1044.
Vidyadhari M, Sujatha M, Krupa P, Nallari P, Venkateshwari A. Association of genetic polymorphism of vascular endothelial growth factor in the etiology of recurrent pregnancy loss: a triad study. J Assist Reprod Genet. 2019;36(5):979‐988.
Sajjadi MS, Ghandil P, Shahbazian N, Saberi A. Association of vascular endothelial growth factor a polymorphisms and aberrant expression of connexin 43 and VEGFA with idiopathic recurrent spontaneous miscarriage. J Obstet Gynaecol Res. 2020;46(3):369‐375.
Traina E, Daher S, Moron AF, Sun SY, Franchim CS, Mattar R. Polymorphisms in VEGF, progesterone receptor and IL‐1 receptor genes in women with recurrent spontaneous abortion. J Reprod Immunol. 2011;88(1):53‐57.
Al‐Khateeb GM, Mustafa FE, Sater MS, Almawi WY. Effect of the functional VEGFA‐583C/T variant on vascular endothelial growth factor levels and the risk of recurrent spontaneous miscarriage. Fertil Steril. 2011;95(8):2471‐2473.
Almawi WY, Saldanha FL, Mahmood NA, Al‐Zaman I, Sater MS, Mustafa FE. Relationship between VEGFA polymorphisms and serum VEGF protein levels and recurrent spontaneous miscarriage. Hum Reprod. 2013;28(10):2628‐2635.
An HJ, Kim JH, Ahn EH, et al. 3′‐UTR polymorphisms in the vascular endothelial growth factor gene (VEGF) contribute to susceptibility to recurrent pregnancy loss (RPL). Int J Mol Sci. 2019;20(13):3319.
Keshavarz L, Yavarian M. The association of Q472H variant in the KDR gene with recurrent pregnancy loss in southern Iran: a case‐control study. Int J Reprod Biomed. 2019;17(7):473‐480.
Rah H, Jeon YJ, Lee BE, et al. Association of kinase insert domain‐containing receptor (KDR) gene polymorphisms with idiopathic recurrent spontaneous abortion in Korean women. Fertil Steril. 2013;99(3):753‐760.e8.
Boldeanu L, Silosi CA, Padureanu V, et al. Determination of VEGFR‐2 (KDR) −604A>G polymorphism in recurrent pregnancy loss. Romanian J Morphol Embryol. 2018;59(4):1053‐1059.
Honarvar N, Sheikhha MH, Farashahi Yazd E, et al. KDR gene polymorphisms and idiopathic recurrent spontaneous abortion. J Matern Fetal Neonatal Med. 2016;29(22):3737‐3740.
Lyons RM, Moses HL. Transforming growth factors and the regulation of cell proliferation. Eur J Biochem. 1990;187(3):467‐473.
Calvo F, Solary E, Gauville C. Transforming growth factors alpha and beta: a review of their characteristics and potential pharmacological applications. Nouv Rev Fr Hematol (1978). 1990;32(1):71‐75.
Hsuan JJ. Transforming growth factors beta. Br Med Bull. 1989;45(2):425‐437.
Wysocka U, Sakowicz A, Jakubowski L, et al. Association between idiopathic recurrent pregnancy loss and genetic polymorphisms in cytokine and matrix metalloproteinase genes. Ginekol Pol. 2021;92(6):440‐445.
Manzoor U, Pandith AA, Amin I, et al. Influence of prominent immunomodulatory cytokines TNF‐alpha308 G>A (rs1800629) and TGFbeta1 G>C (rs1800471) sequence variations as an important contributing factor in etiopathogenesis of recurrent miscarriages in Kashmiri women (North India). J Obstet Gynaecol Res. 2021;47(5):1686‐1693.
von Linsingen R, Bompeixe EP, Bicalho MG. A case‐control study in IL6 and TGFB1 gene polymorphisms and recurrent spontaneous abortion in southern Brazilian patients. Am J Reprod Immunol. 2005;53(2):94‐99.
Amani D, Zolghadri J, Dehaghani AS, Pezeshki AM, Ghaderi A. The promoter region (−800, −509) polymorphisms of transforming growth factor‐beta1 (TGF‐beta1) gene and recurrent spontaneous abortion. J Reprod Immunol. 2004;62(1–2):159‐166.
Magdoud K, Granados Herbepin V, Messaoudi S, et al. Genetic variation in TGFB1 gene and risk of idiopathic recurrent pregnancy loss. Mol Hum Reprod. 2013;19(7):438‐443.
Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9(5):361‐371.
Old LJ. Tumor necrosis factor. Sci Am. 1988;258(5):59‐60, 69‐75.
Yamazaki M. TNF‐alpha. Gan To Kagaku Ryoho. 1994;21(15):2679‐2687.
Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure‐function relationship(s). Microsc Res Tech. 2000;50(3):184‐195.
Romanowska‐Prochnicka K, Felis‐Giemza A, Olesinska M, Wojdasiewicz P, Paradowska‐Gorycka A, Szukiewicz D. The role of TNF‐alpha and anti‐TNF‐alpha agents during preconception, pregnancy, and breastfeeding. Int J Mol Sci. 2021;22(6):2922.
Aboutorabi R, Behzadi E, Sadegh MJ, et al. The study of association between polymorphism of TNF‐alpha Gene's promoter region and recurrent pregnancy loss. J Reprod Infertil. 2018;19(4):211‐218.
Begum A, Mishra A, Das CR, et al. Impact of TNF‐alpha profile in recurrent pregnancy loss pathogenesis: a patient based study from Assam. J Reprod Immunol. 2021;148:103430.
Sudhir N, Badaruddoza BA, Kaur A. Association of tumor necrosis factor‐alpha 308G/A polymorphism with recurrent miscarriages in women. J Hum Reprod Sci. 2016;9(2):86‐89.
Reid JG, Simpson NA, Walker RG, et al. The carriage of pro‐inflammatory cytokine gene polymorphisms in recurrent pregnancy loss. Am J Reprod Immunol. 2001;45(1):35‐40.
Stavros S, Mavrogianni D, Papamentzelopoulou M, et al. Association of tumor necrosis factor‐alpha −308G>A, −238G>A and −376G>A polymorphisms with recurrent pregnancy loss risk in the Greek population. Fertil Res Pract. 2021;7(1):9.
Zammiti W, Mtiraoui N, Finan RR, Almawi WY, Mahjoub T. Tumor necrosis factor alpha and lymphotoxin alpha haplotypes in idiopathic recurrent pregnancy loss. Fertil Steril. 2009;91(5):1903‐1908.
Pietrowski D, Bettendorf H, Keck C, et al. Lack of association of TNFalpha gene polymorphisms and recurrent pregnancy loss in Caucasian women. J Reprod Immunol. 2004;61(1):51‐58.
Prigoshin N, Tambutti M, Larriba J, Gogorza S, Testa R. Cytokine gene polymorphisms in recurrent pregnancy loss of unknown cause. Am J Reprod Immunol. 2004;52(1):36‐41.
Palmirotta R, La Farina F, Ferroni P, et al. TNFA gene promoter polymorphisms and susceptibility to recurrent pregnancy loss in Italian women. Reprod Sci. 2010;17(7):659‐666.
Jang HG, Choi Y, Kim JO, et al. Polymorphisms in tumor necrosis factor‐alpha (−863C>A, −857C>T and +488G>A) are associated with idiopathic recurrent pregnancy loss in Korean women. Hum Immunol. 2016;77(6):506‐511.
Finan RR, Al‐Irhayim Z, Mustafa FE, et al. Tumor necrosis factor‐alpha polymorphisms in women with idiopathic recurrent miscarriage. J Reprod Immunol. 2010;84(2):186‐192.
Ali Rahmani S, Paknejad Z, Mohammadkhanlou M. The effects of tumor necrosis factor‐alpha (TNF‐alpha) and IL‐1 receptor antagonist (IL‐1Ra) polymorphisms on recurrent abortion in Azari women. Ginekol Pol. 2017;88(8):421‐427.
Paul NL, Ruddle NH. Lymphotoxin. Annu Rev Immunol. 1988;6:407‐438.
Ruddle NH. Tumor necrosis factor (TNF‐alpha) and lymphotoxin (TNF‐beta). Curr Opin Immunol. 1992;4(3):327‐332.
Billiau A, Matthys P. Interferon‐gamma: a historical perspective. Cytokine Growth Factor Rev. 2009;20(2):97‐113.
Kelchtermans H, Billiau A, Matthys P. How interferon‐gamma keeps autoimmune diseases in check. Trends Immunol. 2008;29(10):479‐486.
Murphy SP, Tayade C, Ashkar AA, Hatta K, Zhang J, Croy BA. Interferon gamma in successful pregnancies. Biol Reprod. 2009;80(5):848‐859.
Zastavna D, Sosnina K, Terpylyak O, et al. Cytogenetic and immunogenetic analysis of recurrent pregnancy loss in women. Tsitol Genet. 2014;48(4):44‐50.
Wakefield PE, James WD, Samlaska CP, Meltzer MS. Colony‐stimulating factors. J Am Acad Dermatol. 1990;23(5 Pt 1):903‐912.
Metcalf D. The Florey lecture, 1991. The colony‐stimulating factors: discovery to clinical use. Philos Trans R Soc Lond Ser B Biol Sci. 1991;333(1266):147‐173.
Link H. Current state and future opportunities in granulocyte colony‐stimulating factor (G‐CSF). Support Care Cancer. 2022;30(9):7067‐7077.
Nasiri M, Jahangirizadeh K. Granulocyte colony‐stimulating factor gene rs1042658 variant and susceptibility to idiopathic recurrent pregnancy loss: a case‐control study. Int J Reprod Biomed. 2018;16(1):35‐40.
Fedorova L, Khrunin A, Khvorykh G, et al. Analysis of common SNPs across continents reveals major genomic differences between human populations. Genes (Basel). 2022;13(8):1472.